OBJECTIVE: Infections contribute to morbidity and mortality in systemic lupus erythematosus (SLE). Uropathogenic Escherichia coli (UPEC) are known to trigger urinary tract infections (UTIs) and form biofilms, which are multicellular communities of bacteria that are strengthened by amyloids such as curli. We previously reported that curli naturally form complexes with bacterial extracellular DNA (eDNA), and these curli/eDNA complexes induce hallmark features of lupus in mouse models. The present study was undertaken to investigate whether anti-curli/eDNA complex antibodies play a role in the pathogenesis of SLE or development of flares in SLE. METHODS: In total, 96 SLE patients who met at least 4 Systemic Lupus International Collaborating Clinics disease criteria were investigated. Anti-curli/eDNA complex antibodies in the plasma were tested for both IgG and IgA subclasses. Results were compared to that in 54 age-, sex-, and race/ethnicity-matched healthy controls. Correlations of the levels of anti-curli/eDNA antibodies with clinical parameters, lupus disease status, and frequency of bacteriuria were assessed. RESULTS: Anti-curli/eDNA antibodies were detected in the plasma of SLE patients and healthy controls, and their levels correlated with the presence of asymptomatic persistent bacteriuria and occurrence of disease flares in lupus patients. Persistent bacteriuria contained curli-producing UPEC, and this was associated with an inflammatory phenotype. Finally, curli/eDNA complexes cross-reacted with lupus autoantigens, such as double-stranded DNA, in binding autoantibodies. CONCLUSION: These results suggest that UTIs and persistent bacteriuria are environmental triggers of lupus and its flares. Antibodies against curli/eDNA could serve as a sign of systemic exposure to bacterial products in SLE.
OBJECTIVE:Infections contribute to morbidity and mortality in systemic lupus erythematosus (SLE). Uropathogenic Escherichia coli (UPEC) are known to trigger urinary tract infections (UTIs) and form biofilms, which are multicellular communities of bacteria that are strengthened by amyloids such as curli. We previously reported that curli naturally form complexes with bacterial extracellular DNA (eDNA), and these curli/eDNA complexes induce hallmark features of lupus in mouse models. The present study was undertaken to investigate whether anti-curli/eDNA complex antibodies play a role in the pathogenesis of SLE or development of flares in SLE. METHODS: In total, 96 SLEpatients who met at least 4 Systemic Lupus International Collaborating Clinics disease criteria were investigated. Anti-curli/eDNA complex antibodies in the plasma were tested for both IgG and IgA subclasses. Results were compared to that in 54 age-, sex-, and race/ethnicity-matched healthy controls. Correlations of the levels of anti-curli/eDNA antibodies with clinical parameters, lupus disease status, and frequency of bacteriuria were assessed. RESULTS: Anti-curli/eDNA antibodies were detected in the plasma of SLEpatients and healthy controls, and their levels correlated with the presence of asymptomatic persistent bacteriuria and occurrence of disease flares in lupus patients. Persistent bacteriuria contained curli-producing UPEC, and this was associated with an inflammatory phenotype. Finally, curli/eDNA complexes cross-reacted with lupus autoantigens, such as double-stranded DNA, in binding autoantibodies. CONCLUSION: These results suggest that UTIs and persistent bacteriuria are environmental triggers of lupus and its flares. Antibodies against curli/eDNA could serve as a sign of systemic exposure to bacterial products in SLE.
Authors: Matthew R Chapman; Lloyd S Robinson; Jerome S Pinkner; Robyn Roth; John Heuser; Marten Hammar; Staffan Normark; Scott J Hultgren Journal: Science Date: 2002-02-01 Impact factor: 47.728
Authors: Kimberly J Hamilton; Georg Schett; Charles F Reich; Josef S Smolen; David S Pisetsky Journal: Clin Immunol Date: 2005-11-18 Impact factor: 3.969
Authors: M Marcos; C Fernández; A Soriano; F Marco; J A Martínez; M Almela; R Cervera; J Mensa; G Espinosa Journal: Lupus Date: 2011-06-09 Impact factor: 2.911
Authors: Sarah A Tursi; Ernest Y Lee; Nicole J Medeiros; Michael H Lee; Lauren K Nicastro; Bettina Buttaro; Stefania Gallucci; Ronald Paul Wilson; Gerard C L Wong; Çagla Tükel Journal: PLoS Pathog Date: 2017-04-14 Impact factor: 6.823
Authors: Ian N Bruce; Aidan G O'Keeffe; Vern Farewell; John G Hanly; Susan Manzi; Li Su; Dafna D Gladman; Sang-Cheol Bae; Jorge Sanchez-Guerrero; Juanita Romero-Diaz; Caroline Gordon; Daniel J Wallace; Ann E Clarke; Sasha Bernatsky; Ellen M Ginzler; David A Isenberg; Anisur Rahman; Joan T Merrill; Graciela S Alarcón; Barri J Fessler; Paul R Fortin; Michelle Petri; Kristjan Steinsson; Mary Anne Dooley; Munther A Khamashta; Rosalind Ramsey-Goldman; Asad A Zoma; Gunnar K Sturfelt; Ola Nived; Cynthia Aranow; Meggan Mackay; Manuel Ramos-Casals; Ronald F van Vollenhoven; Kenneth C Kalunian; Guillermo Ruiz-Irastorza; Sam Lim; Diane L Kamen; Christine A Peschken; Murat Inanc; Murray B Urowitz Journal: Ann Rheum Dis Date: 2014-05-16 Impact factor: 19.103
Authors: Kaitlyn Grando; Lauren K Nicastro; Sarah A Tursi; Jaime De Anda; Ernest Y Lee; Gerard C L Wong; Çağla Tükel Journal: Front Cell Infect Microbiol Date: 2022-05-11 Impact factor: 6.073
Authors: Lauren K Nicastro; Jaime de Anda; Neha Jain; Kaitlyn C M Grando; Amanda L Miller; Shingo Bessho; Stefania Gallucci; Gerard C L Wong; Çagla Tükel Journal: PLoS Pathog Date: 2022-08-16 Impact factor: 7.464
Authors: Tam D Quach; Weiqing Huang; Ranjit Sahu; Catherine Mm Diadhiou; Chirag Raparia; Roshawn Johnson; Tung Ming Leung; Susan Malkiel; Peta Gay Ricketts; Stefania Gallucci; Çagla Tükel; Chaim O Jacob; Martin L Lesser; Yong-Rui Zou; Anne Davidson Journal: JCI Insight Date: 2022-03-08